Phenotype from SAMD9 Mutation at 7p21.2 Appears Attenuated by Novel Compound Heterozygous Variants at RUNX2 and SALL1

Abstract

Sterile α motif domain-containing protein 9 (SAMD9) is a regulatory protein centrally involved in cell proliferation and apoptosis. Mapped to 7p21.2, variants in SAMD9 have been reported in <50 pediatric cases worldwide, typically with early lethality. Germline gain-of-function SAMD9 variants are associated with MIRAGE syndrome (myelodysplasia, infection, restricted growth, adrenal hypoplasia, genital anomalies, and enteropathy). Spalt like transcription factor 1 (SALL1) is a zinc finger transcriptional repressor located at 16q12.1 where only two transcript variants in SALL1 are known. RUNX2 (6p21.1) encodes a nuclear protein with a Runt DNA-binding domain critical for osteoblastic differentiation, skeletal morphogenesis, and serves as a scaffold for nucleic acids and regulatory factors involved in skeletal gene expression. RUNX2 and SALL1 are thus both “master regulators” of tissue organization and embryo development. Here, we describe exome sequencing and copy number variants in two previously unknown mutations—R824Q in SAMD9, and Q253H in SALL1. A multiexon 3′ terminal duplication of RUNX2 not previously encountered is also reported. This is the first known phenotype assessment for an intersection of all three variants in a healthy 46,XX adult. Focusing on developmental progress, ultrastructural renal anatomy, and selected reproductive aspects, we describe this unique genotype diagnosed incidentally during coronavirus disease 2019 (COVID-19) illness. Individually, disruption in SAMD9, RUNX2, or SALL1 would be expected to give a bleak prognosis. However, this variant convergence appears to dampen severe pathology perhaps by cross-gene silencing of effects normally deleterious when such changes occur alone.

Keywords

SAMD9 - RUNX2 - SALL1 - phenotype - renal structure

Authors' Contributions

E.S.S. organized the research plan, collated data, and assembled the work; S.H.W. contributed to study design and assisted with editing. Both authors read and approved the final manuscript.

Publication History

Received: 29 September 2021

Accepted: 18 October 2021

Article published online:
03 December 2021

• References

• 1 Fischer I, Küchler J, Schaar C. et al. Generation of human induced pluripotent stem cell lines from 2 patients with MIRAGE syndrome. Stem Cell Res (Amst) 2021; 54: 102417
• 2 Ramirez NJ, Posadas-Cantera S, Caballero-Oteyza A, Camacho-Ordonez N, Grimbacher B. There is no gene for CVID - novel monogenetic causes for primary antibody deficiency. Curr Opin Immunol 2021; 72: 176-185
• 3 Narumi S, Amano N, Ishii T. et al. SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7. Nat Genet 2016; 48 (07) 792-797
• 4 Ahmed IA, Farooqi MS, Vander Lugt MT. et al. Outcomes of hematopoietic cell transplantation in patients with germline SAMD9/SAMD9L mutations. Biol Blood Marrow Transplant 2019; 25 (11) 2186-2196
• 5 Ott CE, Leschik G, Trotier F. et al. Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasia. Hum Mutat 2010; 31 (08) E1587-E1593
• 6 Kohlhase J, Taschner PEM, Burfeind P. et al. Molecular analysis of SALL1 mutations in Townes-Brocks syndrome. Am J Hum Genet 1999; 64 (02) 435-445
• 7 Chi D, Zhang W, Jia Y, Cong D, Hu S. Spalt-like transcription factor 1 (SALL1) gene expression inhibits cell proliferation and cell migration of human glioma cells through the Wnt/beta-Catenin signaling pathway. Med Sci Monit Basic Res 2019; 25: 128-138
• 8 Younis NK, Zareef RO, Fakhri G, Bitar F, Eid AH, Arabi M. COVID-19: potential therapeutics for pediatric patients. Pharmacol Rep 2021; 1-19 . Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403523/pdf/43440_2021_Article_316.pdf
• 9 Dong J, Zhang H, Mao X. et al. Novel biallelic mutations in MEI1: expanding the phenotypic spectrum to human embryonic arrest and recurrent implantation failure. Hum Reprod 2021; 36 (08) 2371-2381
• 10 Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS One 2012; 7 (10) e46688
• 11 Kanokwongnuwut P, Martin B, Taylor D, Kirkbride KP, Linacre A. How many cells are required for successful DNA profiling?. Forensic Sci Int Genet 2021; 51: 102453
• 12 Retterer K, Scuffins J, Schmidt D. et al. Assessing copy number from exome sequencing and exome array CGH based on CNV spectrum in a large clinical cohort. Genet Med 2015; 17 (08) 623-629
• 13 Retterer K, Juusola J, Cho MT. et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med 2016; 18 (07) 696-704
• 14 Zheng RF, Su Z, Wang L, Zhao X, Li ZG. [MIRAGE syndrome caused by variation of sterile alpha motif domain-containing protein 9 gene]. Zhonghua Er Ke Za Zhi 2021; 59 (05) 417-419
• 15 Shima H, Koehler K, Nomura Y. et al. Two patients with MIRAGE syndrome lacking haematological features: role of somatic second-site reversion SAMD9 mutations. J Med Genet 2018; 55 (02) 81-85
• 16 Simanshu DK, Nissley DV, McCormick F. RAS proteins and their regulators in human disease. Cell 2017; 170 (01) 17-33
• 17 Wong JC, Bryant V, Lamprecht T. et al. Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes. JCI Insight 2018; 3 (14) e121086
• 18 Ma T, Shi S, Jiang H. et al. A pan-cancer study of spalt-like transcription factors 1/2/3/4 as therapeutic targets. Arch Biochem Biophys 2021; 711: 109016
• 19 Vodopiutz J, Zoller H, Fenwick AL. et al. Homozygous SALL1 mutation causes a novel multiple congenital anomaly-mental retardation syndrome. J Pediatr 2013; 162 (03) 612-617
• 20 Ma C, Wang F, Han B. et al. SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex. Mol Cancer 2018; 17 (01) 78
• 21 Zhu Y, Ortiz A, Costa M. Wrong place, wrong time: Runt-related transcription factor 2/SATB2 pathway in bone development and carcinogenesis. J Carcinog 2021; 20: 2
• 22 Lin Y, Xiao Y, Lin C. et al. SALL1 regulates commitment of odontoblast lineages by interacting with RUNX2 to remodel open chromatin regions. Stem Cells 2021; 39 (02) 196-209
• 23 Vaz-Drago R, Custódio N, Carmo-Fonseca M. Deep intronic mutations and human disease. Hum Genet 2017; 136 (09) 1093-1111
• 24 Moles-Fernández A, Domènech-Vivó J, Tenés A, Balmaña J, Diez O, Gutiérrez-Enríquez S. Role of splicing regulatory elements and in silico tools usage in the identification of deep intronic splicing variants in hereditary breast/ovarian cancer genes. Cancers (Basel) 2021; 13 (13) 3341